TILE · Interface, Inc.

Interface delivered robust Q1 2026 results, with net sales rising 11.3% year-over-year to $331 million, including 6.8% currency-neutral growth, reflecting broad-based strength across product categories and segments. AMS net sales increased 8.7% (8.4% currency neutral), while EAAA surged 15.2% (4.3% currency neutral), driven by corporate office and healthcare momentum with global billings up 16% and 11%, respectively. CEO Laurel Hurd highlighted consistent execution of the One Interface strategy, emphasizing diversified portfolio impact. CFO Bruce Hausmann noted earnings expansion from operational efficiencies. Adjusted gross profit margin expanded 55 basis points to 38.3% due to favorable pricing, product mix, and manufacturing efficiencies, while adjusted SG&A rose on higher commissions but improved as a percent of sales. Adjusted operating income grew 28.6% to $32.7 million. Balance sheet remains solid with net debt of $135.3 million and a low 0.6x net leverage ratio versus LTM adjusted EBITDA of $227.6 million. Confident in momentum, management raised full-year net sales guidance to $1.450-$1.480 billion from prior $1.420-$1.460 billion, with adjusted gross margin narrowed to 38.8%-39.0% and capex increased to $60 million. Q2 outlook targets $385-$395 million in sales at 39.9% adjusted gross margin. Non-GAAP adjustments exclude nora purchase accounting amortization, restructuring, impairments, and other items to reflect core operations. Item 7.01 discloses an updated investor slide presentation (Exhibit 99.2). These results and raised outlook signal sustained profitability and strategic progress.